Wave Life Sciences Ltd (WVE)
Healthcare
Biotechnology
5.70 $
+4.2%
vs. previous close
Closing price · As of: 3. Aug 2026
Wave Life Sciences Ltd (WVE) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -48 million $. Tick rows to compare them in a chart.
| Tick rows to compare them in a chart (up to 4) | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -34 | -33 | -33 | -27 | -46 | -44 | -63 | -46 | -45 | -32 | -60 | -48 | -185 | |
| 2.3 | 2.2 | 2.2 | 2.2 | 2.2 | 2.2 | 2.2 | 2.2 | 2.2 | 2.3 | 1.5 | 1.5 | 7.5 | |
| 2.3 | 2.4 | 2.9 | 3.5 | 3.5 | 3.2 | 5.0 | 6.2 | 6.5 | -18 | 9.1 | 11 | 8.6 | |
| -46 | -21 | -6.9 | -0.2 | 9.6 | -78 | -23 | -3.9 | 0.5 | 10 | -45 | 50 | 16 | |
| 0.2 | 0.4 | 0.4 | 0.1 | 0.4 | 0.1 | 0.2 | 0.3 | 0.2 | 0.0 | 0.4 | 0.9 | 1.6 | |
| -0.2 | -0.4 | -0.4 | -0.1 | -0.4 | -0.1 | -0.2 | -0.3 | -0.2 | 0.0 | -0.4 | -123 | -124 | |
| 1.7 | 94 | 15 | 0.7 | 204 | 35 | 4.2 | 12 | 33 | 443 | 2.5 | -2.2 | 476 | |
| -33 | 60 | -19 | -27 | 157 | -8.9 | -59 | -35 | -12 | 406 | -57 | -174 | 162 | |
| -35 | -34 | -34 | -28 | -47 | -44 | -63 | -46 | -45 | -32 | -60 | -49 | -186 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.